Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment
Despite the reduction in late thrombotic events with newer-generation drug-eluting stents
(DES), late stent failure remains a concern following stent placement. In-stent …
(DES), late stent failure remains a concern following stent placement. In-stent …
Drug-eluting coronary-artery stents
GG Stefanini, DR Holmes Jr - New England Journal of Medicine, 2013 - Mass Medical Soc
Drug-Eluting Coronary-Artery Stents | NEJM Skip to main content NEJM Group Follow Us
Facebook Twitter Instagram YouTube LinkedIn Prepare to become a physician, build your …
Facebook Twitter Instagram YouTube LinkedIn Prepare to become a physician, build your …
Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus-and paclitaxel-eluting stents in humans
Background—Clinical trials have demonstrated that the second-generation cobalt-chromium
everolimus-eluting stent (CoCr-EES) is superior to the first-generation paclitaxel-eluting …
everolimus-eluting stent (CoCr-EES) is superior to the first-generation paclitaxel-eluting …
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction …
Background Newer-generation drug-eluting stents that combine ultrathin strut metallic
platforms with biodegradable polymers might facilitate vascular healing and improve clinical …
platforms with biodegradable polymers might facilitate vascular healing and improve clinical …
Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings
K Kolandaivelu, R Swaminathan, WJ Gibson… - Circulation, 2011 - Am Heart Assoc
Background—Stent thrombosis is a lethal complication of endovascular intervention.
Concern has been raised about the inherent risk associated with specific stent designs and …
Concern has been raised about the inherent risk associated with specific stent designs and …
Paclitaxel-coated balloon angioplasty versus drug-eluting stent in acute myocardial infarction: the REVELATION randomized trial
NS Vos, ND Fagel, G Amoroso, JPR Herrman… - JACC: Cardiovascular …, 2019 - jacc.org
Objectives: This study sought to assess the efficacy and safety of a drug-coated balloon
(DCB) strategy versus drug-eluting stent (DES) in primary percutaneous coronary …
(DCB) strategy versus drug-eluting stent (DES) in primary percutaneous coronary …
Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis
T Inoue, K Croce, T Morooka, M Sakuma… - JACC: Cardiovascular …, 2011 - jacc.org
The cellular and molecular processes that control vascular injury responses after
percutaneous coronary intervention involve a complex interplay among vascular cells and …
percutaneous coronary intervention involve a complex interplay among vascular cells and …
1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis
Background Compared with metallic drug-eluting stents, bioresorbable vascular scaffolds
(BVS) offer the potential to improve long-term outcomes of percutaneous coronary …
(BVS) offer the potential to improve long-term outcomes of percutaneous coronary …
Intracoronary optical coherence tomography: a comprehensive review: clinical and research applications
Cardiovascular optical coherence tomography (OCT) is a catheter-based invasive imaging
system. Using light rather than ultrasound, OCT produces high-resolution in vivo images of …
system. Using light rather than ultrasound, OCT produces high-resolution in vivo images of …
In-stent neoatherosclerosis: a final common pathway of late stent failure
SJ Park, SJ Kang, R Virmani, M Nakano… - Journal of the American …, 2012 - jacc.org
Percutaneous coronary intervention with stenting is the most widely performed procedure for
the treatment of symptomatic coronary disease, and drug-eluting stents (DES) have …
the treatment of symptomatic coronary disease, and drug-eluting stents (DES) have …